Acrow India Limited has submitted its quarterly compliance certificate to BSE Limited in accordance with regulatory requirements for the quarter and financial year ended March 31, 2026. The filing demonstrates the company's adherence to SEBI depositories regulations and proper corporate governance practices.

Regulatory Compliance Filing

The compliance certificate was filed on April 14, 2026, pursuant to Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018. Company Secretary and Compliance Officer Arvind Kumar Modi signed and submitted the documentation to BSE Limited's Department of Corporate Services.

Share Transfer Agent Confirmation

Adroit Corporate Services Private Limited, serving as the company's share transfer agent, provided confirmation regarding dematerialisation processes during the quarter. The agent confirmed that securities received from depository participants for dematerialisation during the quarter ended March 31, 2026, were properly processed and confirmed to the depositories.

The confirmation certificate, dated April 1, 2026, verified that:

• Securities received for dematerialisation were confirmed to depositories
• Security certificates were mutilated and cancelled after due verification
• Depository names were substituted in the register of members within the prescribed 15-day timeframe
• All securities are listed on stock exchanges where previously issued securities are traded

Corporate Information

Acrow India Limited operates from its registered office at Plot No. T-27, STPI Park, M.I.D.C., Chikalthana, Chhatrapati Sambhaji Nagar, Maharashtra. The company maintains its corporate identification number as L46411MH1960PLC011601 and can be contacted at csacrowindialtd@gmail.com .

The filing represents routine regulatory compliance, ensuring transparency in the company's share transfer and dematerialisation processes as mandated by SEBI regulations for listed companies.

Acrow Limited has provided a detailed explanation to BSE Limited regarding the delayed submission of board meeting outcomes, citing an unforeseen medical emergency that prevented timely regulatory compliance. The company's clarification, dated March 5, 2026, addresses concerns raised by the stock exchange regarding non-compliance with SEBI LODR Regulations.

Emergency Circumstances Behind Delay

The delay occurred when Company Secretary Arvind Mody had to urgently attend to a medical emergency at his residence immediately after the board meeting concluded. This unforeseen situation, combined with intervening non-working days, prevented the completion and uploading of the board meeting outcome within the prescribed regulatory timeline.

Company's Response and Corrective Measures

Acrow Limited emphasized that the delay was completely unintentional and circumstantial, with no deliberate attempt to withhold or suppress material information from the stock exchange or investors. The company highlighted its consistent record of regulatory compliance and commitment to adhering to SEBI LODR provisions.

To prevent similar situations in the future, the company has implemented strengthened internal processes:

• Alternate compliance mechanisms established
• Additional signatory arrangements put in place
• Enhanced backup procedures for regulatory filings

Request for Exemption

The company has requested BSE Limited to grant exemption from penalties, citing several factors:

• Bona fide and unavoidable nature of the delay
• Absence of mala fide intent
• Prompt corrective action taken upon resumption of duties
• No prejudice caused to investors or market participants

Acrow Limited maintains that the disclosure was filed immediately when the Company Secretary resumed office, demonstrating the company's commitment to transparency and regulatory compliance despite the challenging circumstances.